Adrenergic alpha-1, alpha-2A, and alpha-2B receptors (α1, α2A, α2B adrenergic receptors)

Adrenergic alpha-1, alpha-2A, and alpha-2B receptors are subtypes of the adrenergic receptor superfamily, which are G protein-coupled receptors activated by endogenous catecholamines such as norepinephrine and epinephrine[5][6][7]. - Alpha-1 adrenergic receptors (including α1A) are primarily associated with Gq protein signaling, leading to smooth muscle contraction, vasoconstriction, regulation of blood pressure, and multiple other physiological responses[5][7]. - Alpha-2 adrenergic receptors (including α2A and α2B) couple mainly to Gi proteins, resulting in inhibition of adenylyl cyclase, decreased norepinephrine release, CNS effects (sedation, analgesia), and regulation of blood glucose and vascular tone[1][7]. These receptors are major pharmacological targets for drugs used to treat hypertension, benign prostatic hyperplasia, attention-deficit hyperactivity disorder (ADHD), and for perioperative sedation[5][6][7][4]. While they share substantial homology and some overlapping functions, their tissue distributions, physiological effects, and roles in disease are distinct. Drugs may be selective for one subtype, which can provide therapeutic specificity or reduce unwanted side effects[4][6][7].

Other names

alpha-adrenergic receptoradrenoceptor alpha-1adrenoceptor alpha-2Aadrenoceptor alpha-2Bα-adrenoceptor

Agonists: activate adrenergic receptors to mimic endogenous catecholamines, leading to vasoconstriction, CNS effects, or inhibition of neurotransmitter release (α2) Antagonists: block endogenous catecholamines, leading to vasodilation, decreased blood pressure, relaxation of smooth muscle